drugset / Trial / NCT02808325

Study on the Efficacy and Safety of Gelaspan

NCT02808325

Phase 3 Completed 72 enrolled B. Braun Medical SA
RandomizedParallel-groupQuadruple-blindTreatment

Summary

It is the objective of the study to investigate the efficacy and safety of two different volume replacement regimens with gelatine solutions.

Timeline

Start
2016-06
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gelaspan Other / unclassified 4 %
Comparator Gelofusine Other / unclassified 4 %